Navigation Links
Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
Date:8/19/2007

ANNAPOLIS, Md., Aug. 17 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP) announced today that a hearing has been scheduled by the Delaware Court of Chancery for 2:00 p.m. on Monday, August 27, 2007, in an action filed by PharmAthene stockholder Matthew P. Kinley pursuant to Section 225(b) of the Delaware General Corporation Law seeking a determination from the Delaware Court of Chancery that the merger between PharmAthene, Inc. and Healthcare Acquisition Corp. (the "Merger") was validly approved at the Special Meeting of Stockholders of Healthcare Acquisition Corp. on August 3, 2007 and thereafter consummated by the filing of a Certificate of Merger with the Delaware Secretary of State. By this press release, PharmaAthene is providing notice to all holders of the common stock of PharmAthene, Inc. (formerly known as Healthcare Acquisition Corp.) of the pending judicial action in the Delaware Court of Chancery.

As previously disclosed in the press release dated August 6, 2007, the tabulation of the number of shares demanding conversion into a right to receive cash rather than shares in the post-merger entity was initially misreported to the Special Meeting of Stockholders of Healthcare Acquisition Corp. by its transfer agent. Following that misreporting, certain of the officers, directors and stockholders of Healthcare Acquisition Corp. and certain stockholders of PharmAthene purchased additional shares of common stock of Healthcare Acquisition Corp., reducing the number of conversion elections and allowing for consummation of the Merger. In his Complaint, PharmAthene stockholder Matthew P. Kinley alleges that the stockholder action taken at the Special Meeting of Stockholders of Healthcare Acquisition Corp.
'/>"/>

SOURCE PharmAthene, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Green County courts to hold hearings via video conferencing
2. Public Hearing Held for controversial anti-cloning bills
3. Delaware company will keep NameProtect here
4. Wisconsin Supreme Court to hear Menasha software case
5. Supreme Court limits foreign reach of U.S. patents
6. High court sends message on patent obviousness
7. Supreme Court ruling seen as blow to WARF stem cell patents
8. Software tax dispute could go the Supreme Court
9. Wisconsin court halts Abbotts sale of genotyping products
10. Wisconsin court affirms damages in Innogenetics, Abbott patent case
11. With patents, Wisconsin court gaining reputation as a "rocket docket"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), ... China , today announced that it will release ... June 30, 2015, after market close on Wednesday, August ... Thursday, August 13, 2015, at 8:00 a.m. EDT (Thursday, ... to review the Company,s financial results and provide an ...
(Date:8/3/2015)... -- At the 11th hour, ... shortfall of Jude Liversage,s campaign so the ... time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ) ... The Selective Dorsal Rhizotomy (SDR) procedure reduced the ... his wish to kick a ball around like his ...
(Date:8/3/2015)... Aug. 3, 2015  Merck KGaA, Darmstadt, ... top-quality high-tech products in the healthcare, life science and ... company Nano-C, their development and launch of promising new ... (OPV). Merck KGaA, Darmstadt, Germany , ... OPV sector. Novel derivatives: highly stable, easy ...
(Date:8/3/2015)... 3, 2015 E-QURE Corp. (OTCQB: ... its Bio-electrical Signal Therapy device ("BST Device"), a new ... to heal chronic wounds, today announced that the Company ... Israeli distributor specializing in medical devices, for the marketing ... is a 70 years old, sales, marketing and distribution ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3
... Joseph F. Finn, Jr., C.P.A. ("Finn"), announced ... been assigned to him for the benefit of Prospect,s ... designed to inhibit the activity of galectin-3, a protein ... human cancers and whose over-expression is associated with poor ...
... Sponsoring BrandsCINCINNATI, May 12 Healthy Advice ... office-based patient-education programs, announces another record performance in ... company continued to experience double-digit growth, posting 21% ... programs (a digital screen waiting room program and ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... present a company update at the Deutsche Bank 34th Annual ... at 1:55 p.m. ET. Interested parties may access a ... section of the BioMarin website, www.BMRN.com . ...
Cached Biology Technology:Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors 2Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy 2BioMarin to Present at the Deutsche Bank Health Care Conference 2
(Date:7/31/2015)... 31 de julio de 2015 BGI llevará a ... ) del 22 al 25 de octubre de 2015, ... La conferencia celebra su décimo aniversario este año. Desde ... una de las reuniones anuales más influyentes del mundo ... de las conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/27/2015)... Calif. , July 27, 2015  Synaptics ... of human interface solutions, today announced that Huawei ... touchscreen solution for its stylish smartwatch. Huawei ... its proven reliability, low power and highly responsive ... wet finger. Huawei designers also required a classic ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... Researchers at the University of Iowa have created a ... putting DNA into a nano-sized particle that delivers bone-producing ... on a collagen platform seeded with particles containing the ... bio patch successfully regrew bone fully enough to cover ...
... drug-resistant breast cancer cells, according to a study published ... are just as small, or even smaller, than many ... of healthy and sick cells, which make them interesting ... In the present study, researchers from Karolinska Institutet ...
... for Brain Science announced today that it contracted ... and manufacture a state-of-the-art sensor array for recording ... for Brain Science in partnership with the Howard ... the Wellcome Trust and University College London (UCL), ...
Cached Biology News:A bio patch that can regrow bone 2A bio patch that can regrow bone 3Nanoparticles can overcome drug resistance in breast cancer cells 2Allen Institute for Brain Science partners with imec for development of next-generation tools 2
... Rabbit polyclonal to JAK2 (phospho Y1007) ... applications). Antigen: ... around the phosphorylation site of tyrosine ... Entrez Gene ID: 3717 ...
... Fixation Buffer, used in conjunction with ... can be used to fix and ... staining of cytokines and other cytoplasmic ... been specially formulated for reducing non-specific ...
Harmful, Irritant, Combustible ,DEPC...
... ( Abpromise for all tested applications). ... conjugated to KLH derived from within residues ... amino acid sequence is proprietary)(Peptide available as ... Gene ID: 55693 ...
Biology Products: